Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-151200CALL0 0260.22TRUE00
2025-08-151250CALL0 0241.52TRUE00
2025-08-151300CALL0 0223.44TRUE00
2025-08-151350CALL0 0205.91TRUE00
2025-08-1514045.23CALL0 20177.1TRUE00
2025-08-1514540.48CALL0 20172.28TRUE00
2025-08-1515017.55CALL0 9156.04TRUE00
2025-08-1515517.84CALL0 2142.36TRUE00
2025-08-1516019.7CALL0 20124.38TRUE00
2025-08-1516514.5CALL0 768.95TRUE00
2025-08-1517017.5CALL0 867.39TRUE00
2025-08-1517518CALL4 9270.84TRUE0.40.02
2025-08-151805.85CALL26 105160.84TRUE-5.15-0.47
2025-08-151853CALL12 1351.45TRUE-7.7-0.72
2025-08-151909.6CALL26 103057.95TRUE2.010.26
2025-08-151953.79CALL19 2853.72FALSE-2.56-0.4
2025-08-152001.97CALL30 149550.96FALSE-1.93-0.49
2025-08-152100.85CALL13 101859.35FALSE-1.21-0.59
2025-08-152200.05CALL2 447.45FALSE-0.85-0.94
2025-08-152300CALL0 0104.08FALSE00
2025-08-152400CALL0 0120.69FALSE00
2025-08-152500CALL0 0136.63FALSE00
2025-08-152600CALL0 0136.89FALSE00
2025-08-151200PUT0 0229.41FALSE00
2025-08-151250.38PUT0 1212.53FALSE00
2025-08-151300PUT0 0197.24FALSE00
2025-08-151350.85PUT0 1181.35FALSE00
2025-08-151400.4PUT10 11135.6FALSE0.40
2025-08-151451.26PUT0 19150.86FALSE00
2025-08-151500.02PUT1 572.23FALSE-1.23-0.98
2025-08-151552PUT0 8123.11FALSE00
2025-08-151601.25PUT10 140111.9FALSE-1.07-0.46
2025-08-151650.5PUT12 80677.11FALSE-3-0.86
2025-08-151700.05PUT12 104091.61FALSE-3.95-0.99
2025-08-151752.4PUT10 156587.07FALSE-2.1-0.47
2025-08-151801.26PUT15 1253.64FALSE-5.24-0.81
2025-08-151857.2PUT4 79958.14FALSE-0.5-0.06
2025-08-151902.65PUT1 059.68FALSE2.650
2025-08-1519517.45PUT2 261.29TRUE4.060.3
2025-08-152000PUT0 058.13TRUE00
2025-08-1521024.83PUT2 360.42TRUE2.030.09
2025-08-152200PUT0 073.09TRUE00
2025-08-152300PUT0 092.05TRUE00
2025-08-152400PUT0 0106.38TRUE00
2025-08-152500PUT0 0116.96TRUE00
2025-08-152600PUT0 0132.92TRUE00
2025-09-19750CALL0 0179.11TRUE00
2025-09-19800CALL0 0169.67TRUE00
2025-09-19850CALL0 0158.77TRUE00
2025-09-19900CALL0 0148.53TRUE00
2025-09-19950CALL0 0138.87TRUE00
2025-09-191000CALL0 0131.43TRUE00
2025-09-191050CALL0 0122.66TRUE00
2025-09-191100CALL0 0114.31TRUE00
2025-09-191150CALL0 0107.77TRUE00
2025-09-191200CALL0 098.68TRUE00
2025-09-1912563.5CALL1 084.13TRUE63.50
2025-09-191300CALL0 086.7TRUE00
2025-09-191350CALL0 081.95TRUE00
2025-09-1914035.5CALL0 176.1TRUE00
2025-09-191450CALL0 043.22TRUE00
2025-09-1915028CALL0 144.71TRUE00
2025-09-1915524.55CALL0 147.35TRUE00
2025-09-1916019.54CALL0 147.65TRUE00
2025-09-1916522.6CALL0 147.03TRUE00
2025-09-1917017.1CALL0 26247.45TRUE00
2025-09-1917514.13CALL0 1048.3TRUE00
2025-09-191807.85CALL0 6847.17TRUE00
2025-09-1918516.8CALL5 34650.84TRUE16.80
2025-09-1919014.31CALL8 1244.01TRUE14.310
2025-09-191958.47CALL0 344.16FALSE00
2025-09-192009.1CALL16 57647.92FALSE1.390.18
2025-09-192105.88CALL14 447.72FALSE0.080.01
2025-09-192204.9CALL1 442.81FALSE4.90
2025-09-192301.8CALL1 344.74FALSE1.80
2025-09-192401.25CALL1 50047.2FALSE1.250
2025-09-192500.8CALL0 152.94FALSE00
2025-09-192600.35CALL0 157.9FALSE00
2025-09-19750PUT0 0162.43FALSE00
2025-09-19800PUT0 0152.32FALSE00
2025-09-19850PUT0 0142.85FALSE00
2025-09-19900PUT0 0133.93FALSE00
2025-09-19950PUT0 0125.49FALSE00
2025-09-191000PUT0 0117.48FALSE00
2025-09-191050PUT0 0109.85FALSE00
2025-09-191100PUT0 0102.55FALSE00
2025-09-191150PUT0 095.56FALSE00
2025-09-191200PUT0 088.84FALSE00
2025-09-191251.85PUT0 182.36FALSE00
2025-09-191302.4PUT0 276.87FALSE00
2025-09-191352.6PUT0 171.11FALSE00
2025-09-191403.3PUT0 166.12FALSE00
2025-09-191454.9PUT0 161.71FALSE00
2025-09-191503PUT0 101957.43FALSE00
2025-09-191552.5PUT10 260.1FALSE2.50
2025-09-191602.8PUT1 2155.87FALSE2.80
2025-09-191654PUT10 21956.78FALSE40
2025-09-1917015.85PUT0 21349.81FALSE00
2025-09-1917518.44PUT0 249.48FALSE00
2025-09-191808.5PUT0 1450.07FALSE00
2025-09-1918520.4PUT0 348.67FALSE00
2025-09-1919011.52PUT2 149.75FALSE11.520
2025-09-191950PUT0 046.25TRUE00
2025-09-192000PUT0 045.89TRUE00
2025-09-192100PUT0 044.59TRUE00
2025-09-1922033.7PUT5 045.32TRUE33.70
2025-09-192300PUT0 046.68TRUE00
2025-09-192400PUT0 047.06TRUE00
2025-09-192500PUT0 052.12TRUE00
2025-09-192600PUT0 057.24TRUE00
2025-10-17750CALL0 0139.27TRUE00
2025-10-17800CALL0 0130.05TRUE00
2025-10-1785103.5CALL1 0122.98TRUE103.50
2025-10-17900CALL0 0114.83TRUE00
2025-10-17950CALL0 0108.53TRUE00
2025-10-171000CALL0 0101.22TRUE00
2025-10-171050CALL0 095.51TRUE00
2025-10-171100CALL0 088.85TRUE00
2025-10-171150CALL0 083.61TRUE00
2025-10-171200CALL0 078.51TRUE00
2025-10-171250CALL0 074.5TRUE00
2025-10-171300CALL0 037.29TRUE00
2025-10-171350CALL0 043.04TRUE00
2025-10-171400CALL0 043.73TRUE00
2025-10-171450CALL0 045.58TRUE00
2025-10-171500CALL0 045.52TRUE00
2025-10-1715529.75CALL0 746TRUE00
2025-10-171600CALL0 045.33TRUE00
2025-10-171650CALL0 044.98TRUE00
2025-10-1717021.5CALL0 644.57TRUE00
2025-10-171750CALL0 043.86TRUE00
2025-10-1718024.5CALL1 543.19TRUE24.50
2025-10-1718519.2CALL2 145.68TRUE19.20
2025-10-1719015.8CALL6 1543.16TRUE15.80
2025-10-171959.93CALL10 1040.23FALSE9.930
2025-10-1720010.5CALL198 29640.4FALSE-1-0.09
2025-10-172106.1CALL3 136.87FALSE0.050.01
2025-10-172200CALL0 237FALSE00
2025-10-172302.05CALL0 336.67FALSE00
2025-10-172403CALL1 346.01FALSE30
2025-10-172501.4CALL0 241.18FALSE00
2025-10-172601.1CALL1 344.03FALSE1.10
2025-10-17750PUT0 0125.59FALSE00
2025-10-17800PUT0 0117.8FALSE00
2025-10-17850PUT0 0110.5FALSE00
2025-10-17900PUT0 0103.62FALSE00
2025-10-17950PUT0 097.12FALSE00
2025-10-171000PUT0 090.94FALSE00
2025-10-171050PUT0 185.06FALSE00
2025-10-171100PUT0 179.44FALSE00
2025-10-171150PUT0 074.41FALSE00
2025-10-171201.85PUT0 169.54FALSE00
2025-10-171252.45PUT0 265.13FALSE00
2025-10-171302.9PUT0 361.09FALSE00
2025-10-171351.43PUT1 158.12FALSE1.430
2025-10-171400PUT0 050.36FALSE00
2025-10-171450PUT0 050.95FALSE00
2025-10-171500PUT0 048.78FALSE00
2025-10-171550PUT0 048.44FALSE00
2025-10-171600PUT0 047.47FALSE00
2025-10-171650PUT0 047.43FALSE00
2025-10-171709.1PUT300 046.88FALSE9.10
2025-10-1717510.9PUT0 045.71FALSE00
2025-10-171800PUT0 045.83FALSE00
2025-10-171850PUT0 044.13FALSE00
2025-10-171900PUT0 043.4FALSE00
2025-10-171950PUT0 042.31TRUE00
2025-10-1720021.82PUT2 342.05TRUE0.320.01
2025-10-172100PUT0 042.05TRUE00
2025-10-172200PUT0 040.82TRUE00
2025-10-1723051PUT1 039.88TRUE510
2025-10-1724070PUT0 039.56TRUE00
2025-10-172500PUT0 042.96TRUE00
2025-10-172600PUT0 047.21TRUE00
2025-12-19600CALL0 0124.45TRUE00
2025-12-19650CALL0 0116.89TRUE00
2025-12-19700CALL0 0109.92TRUE00
2025-12-19750CALL0 1103.46TRUE00
2025-12-19800CALL0 097.43TRUE00
2025-12-19850CALL0 091.77TRUE00
2025-12-19900CALL0 086.43TRUE00
2025-12-19950CALL0 082.3TRUE00
2025-12-191000CALL0 048.74TRUE00
2025-12-191050CALL0 050.51TRUE00
2025-12-191100CALL0 054.2TRUE00
2025-12-191150CALL0 054.76TRUE00
2025-12-191200CALL0 055.16TRUE00
2025-12-191250CALL0 3855.04TRUE00
2025-12-191300CALL0 154.56TRUE00
2025-12-191350CALL0 154.55TRUE00
2025-12-191400CALL0 354.36TRUE00
2025-12-1914545.54CALL0 254.03TRUE00
2025-12-1915037.5CALL0 254.25TRUE00
2025-12-191550CALL0 053.44TRUE00
2025-12-191600CALL0 6652.99TRUE00
2025-12-1916531CALL0 152.54TRUE00
2025-12-1917035.4CALL0 7151.69TRUE00
2025-12-1917531.9CALL0 550.98TRUE00
2025-12-1918028.8CALL0 8650.61TRUE00
2025-12-1918526.1CALL0 1949.98TRUE00
2025-12-1919023.7CALL0 649.43TRUE00
2025-12-1919521.5CALL0 6148.53FALSE00
2025-12-1920020.6CALL1 21350FALSE0.60.03
2025-12-1921017.9CALL1 8646.43FALSE17.90
2025-12-192207.75CALL2 6645.5FALSE-4.05-0.34
2025-12-192305CALL0 144.11FALSE00
2025-12-192406CALL0 544.14FALSE00
2025-12-192502.5CALL0 642.79FALSE00
2025-12-192605.3CALL1 848.2FALSE5.30
2025-12-192703.8CALL1 046.81FALSE3.80
2025-12-19600PUT0 0111.01FALSE00
2025-12-19650PUT0 1103.94FALSE00
2025-12-19700PUT0 097.42FALSE00
2025-12-19750PUT0 091.38FALSE00
2025-12-19800PUT0 2085.75FALSE00
2025-12-19850PUT0 180.83FALSE00
2025-12-19900PUT0 2176.18FALSE00
2025-12-19950PUT0 172.07FALSE00
2025-12-191000PUT0 168.41FALSE00
2025-12-191052.1PUT0 365.62FALSE00
2025-12-191102.65PUT0 462.77FALSE00
2025-12-191152.5PUT0 159.9FALSE00
2025-12-191203.4PUT0 357.74FALSE00
2025-12-191250PUT0 159.32FALSE00
2025-12-191300PUT0 156.26FALSE00
2025-12-191350PUT0 156.12FALSE00
2025-12-191409.23PUT0 7654.67FALSE00
2025-12-191450PUT0 155.13FALSE00
2025-12-191500PUT0 054.27FALSE00
2025-12-191550PUT0 053.97FALSE00
2025-12-191600PUT0 053.81FALSE00
2025-12-191650PUT0 053.06FALSE00
2025-12-1917018.7PUT0 11052.59FALSE00
2025-12-191750PUT0 051.97FALSE00
2025-12-191800PUT0 051.33FALSE00
2025-12-1918527.5PUT0 16650.32FALSE00
2025-12-191900PUT0 049.41FALSE00
2025-12-191950PUT0 049.14TRUE00
2025-12-1920030.4PUT1 1748.28TRUE1.40.05
2025-12-192100PUT0 146.64TRUE00
2025-12-1922051.9PUT0 345.64TRUE00
2025-12-192300PUT0 044.65TRUE00
2025-12-192400PUT0 144.26TRUE00
2025-12-192500PUT0 043.64TRUE00
2025-12-1926077.4PUT0 043.62TRUE00
2025-12-192700PUT0 044.38TRUE00
2026-01-16750CALL0 093.78TRUE00
2026-01-16800CALL0 089.19TRUE00
2026-01-16850CALL0 083.87TRUE00
2026-01-16900CALL0 079.75TRUE00
2026-01-16950CALL0 039.09TRUE00
2026-01-161000CALL0 048.19TRUE00
2026-01-161050CALL0 051.4TRUE00
2026-01-161100CALL0 052.23TRUE00
2026-01-161150CALL0 052.43TRUE00
2026-01-161200CALL0 052.91TRUE00
2026-01-161250CALL0 052.61TRUE00
2026-01-161300CALL0 052.03TRUE00
2026-01-1613545.5CALL0 152.11TRUE00
2026-01-161400CALL0 051.83TRUE00
2026-01-161450CALL0 052.13TRUE00
2026-01-1615037.5CALL0 051.89TRUE00
2026-01-161550CALL0 051.67TRUE00
2026-01-1616035.98CALL0 651.05TRUE00
2026-01-1616524.85CALL0 2151.34TRUE00
2026-01-1617034.64CALL0 21149.92TRUE00
2026-01-1617525.7CALL0 650.16TRUE00
2026-01-161800CALL0 549.59TRUE00
2026-01-1618526CALL0 1748.82TRUE00
2026-01-1619027CALL4 549.09TRUE0.530.02
2026-01-1619525CALL2 449.52FALSE250
2026-01-1620021.6CALL2 446.87FALSE21.60
2026-01-1621013.2CALL0 344.99FALSE00
2026-01-162209.5CALL0 044.11FALSE00
2026-01-1623012CALL1 42146.64FALSE120
2026-01-162407.2CALL0 142.28FALSE00
2026-01-162504.83CALL0 342.21FALSE00
2026-01-162600CALL0 041.96FALSE00
2026-01-162700CALL0 041.56FALSE00
2026-01-16750PUT0 083.25FALSE00
2026-01-16800PUT0 078.13FALSE00
2026-01-16850PUT0 073.66FALSE00
2026-01-16900PUT0 069.44FALSE00
2026-01-16950PUT0 065.71FALSE00
2026-01-161000PUT0 062.9FALSE00
2026-01-161050PUT0 060.31FALSE00
2026-01-161100PUT0 057.69FALSE00
2026-01-161150PUT0 056.14FALSE00
2026-01-161200PUT0 054.35FALSE00
2026-01-161250PUT0 054.04FALSE00
2026-01-161300PUT0 553.93FALSE00
2026-01-161355.23PUT9 2757.01FALSE5.230
2026-01-161406.25PUT8 1956.59FALSE6.250
2026-01-161450PUT0 1453.27FALSE00
2026-01-1615010.9PUT0 853.17FALSE00
2026-01-161550PUT0 052.79FALSE00
2026-01-1616012.25PUT2 052.42FALSE12.250
2026-01-1616513.9PUT17 1955.94FALSE13.90
2026-01-1617020.3PUT0 951.24FALSE00
2026-01-1617526.1PUT0 150.67FALSE00
2026-01-161800PUT0 050.11FALSE00
2026-01-1618527.9PUT0 549.75FALSE00
2026-01-1619032.1PUT0 248.68FALSE00
2026-01-161950PUT0 048.31TRUE00
2026-01-162000PUT0 047.73TRUE00
2026-01-162100PUT0 046.76TRUE00
2026-01-162200PUT0 045.36TRUE00
2026-01-162300PUT0 044.49TRUE00
2026-01-162400PUT0 043.47TRUE00
2026-01-162500PUT0 043.14TRUE00
2026-01-162600PUT0 042.69TRUE00
2026-01-162700PUT0 042.8TRUE00
2026-06-18800CALL0 052.75TRUE00
2026-06-18850CALL0 053.09TRUE00
2026-06-18900CALL0 052.68TRUE00
2026-06-18950CALL0 053.49TRUE00
2026-06-181000CALL0 052.16TRUE00
2026-06-181050CALL0 053.09TRUE00
2026-06-181100CALL0 052.32TRUE00
2026-06-181150CALL0 052.22TRUE00
2026-06-181200CALL0 052.58TRUE00
2026-06-181250CALL0 052.08TRUE00
2026-06-181300CALL0 051.87TRUE00
2026-06-181350CALL0 051.51TRUE00
2026-06-181400CALL0 1051.26TRUE00
2026-06-181450CALL0 050.77TRUE00
2026-06-181500CALL0 051.08TRUE00
2026-06-1815551.5CALL0 250.26TRUE00
2026-06-1816049CALL0 249.84TRUE00
2026-06-1816536.9CALL0 249.66TRUE00
2026-06-1817037CALL0 1049.38TRUE00
2026-06-1817545.2CALL2 149.56TRUE45.20
2026-06-1818040.44CALL0 948.37TRUE00
2026-06-1818531.8CALL0 148.13TRUE00
2026-06-1819025.6CALL0 547.73TRUE00
2026-06-181950CALL0 047.17FALSE00
2026-06-1820025.8CALL0 346.84FALSE00
2026-06-1821025CALL0 1545.44FALSE00
2026-06-1822020.6CALL0 245.12FALSE00
2026-06-1823018.6CALL0 443.69FALSE00
2026-06-182400CALL0 042.63FALSE00
2026-06-1825013.5CALL0 142.01FALSE00
2026-06-182600CALL0 041.67FALSE00
2026-06-182700CALL0 041.45FALSE00
2026-06-18800PUT0 060.66FALSE00
2026-06-18850PUT0 058.19FALSE00
2026-06-18900PUT0 056.11FALSE00
2026-06-18950PUT0 055.22FALSE00
2026-06-181000PUT0 053.53FALSE00
2026-06-181050PUT0 053.05FALSE00
2026-06-181100PUT0 052.74FALSE00
2026-06-181150PUT0 052.9FALSE00
2026-06-181200PUT0 052.73FALSE00
2026-06-181250PUT0 052.24FALSE00
2026-06-181309.08PUT2 255.31FALSE9.080
2026-06-181350PUT0 051.91FALSE00
2026-06-181400PUT0 051.85FALSE00
2026-06-181450PUT0 050.89FALSE00
2026-06-1815016.25PUT0 250.68FALSE00
2026-06-1815522.5PUT0 150.52FALSE00
2026-06-1816018.98PUT2 049.97FALSE18.980
2026-06-1816525.21PUT0 249.41FALSE00
2026-06-1817025.05PUT0 248.93FALSE00
2026-06-1817526.3PUT0 4448.36FALSE00
2026-06-1818033.3PUT0 948.17FALSE00
2026-06-1818535.6PUT0 847.95FALSE00
2026-06-181900PUT0 047.33FALSE00
2026-06-181950PUT0 046.92TRUE00
2026-06-1820044.5PUT0 246.78TRUE00
2026-06-182100PUT0 045.81TRUE00
2026-06-182200PUT0 045.01TRUE00
2026-06-182300PUT0 044.31TRUE00
2026-06-182400PUT0 043.35TRUE00
2026-06-182500PUT0 042.93TRUE00
2026-06-1826090.48PUT0 26942.31TRUE00
2026-06-182700PUT0 041.92TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm